Quantcast

Tag Archives: generic drugs

Hopkins professors urge justices to hear generic drugs appeal

"If all you're getting from your school system is here's everything that we're doing to reduce the chance of infection, that's not enough," says Dr. Joshua Sharfstein of Johns Hopkins. "People should also know what should happen, when and if there's a case of coronavirus in the  schools."(File photo)

Two Johns Hopkins medical school professors are urging the U.S. Supreme Court to revive a Maryland law aimed at preventing unwarranted price increases for generic drugs, calling access to affordable pharmaceuticals “a crucial issue for the public health.” In papers ...

Read More »

Justices show interest in Frosh’s generic-drugs appeal

01.06.14 BALTIMORE, MD- Stephen Wienner, Owner and Pharmacist at  Mt. Vernon Pharmacy, shown here with some generic pharmaceuticals for a story about the rising price of generic drugs. (The Daily Record/Maximilian Franz)

The Supreme Court is showing an interest in Maryland Attorney General Brian E. Frosh’s request that the justices revive the state’s law aimed at preventing unwarranted price increases for generic drugs. On Tuesday the high court asked that the generic-drug ...

Read More »

Generics industry waives response to Frosh’s Supreme Court appeal

A law scheduled to go into effect next month would prohibit a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug and gives the Maryland attorney general the power to order the manufacturer to submit a statement explaining the reasons behind a significant price increase. (Deposit Photos)

A generic-drug industry group will wait to be asked by the U.S. Supreme Court before responding to Maryland Attorney General Brian E. Frosh’s request that the justices revive the state’s law aimed at preventing unwarranted price increases for the pharmaceuticals. ...

Read More »

4th Circuit lets generic drug price-gouging ruling stand

A law scheduled to go into effect next month would prohibit a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug and gives the Maryland attorney general the power to order the manufacturer to submit a statement explaining the reasons behind a significant price increase. (Deposit Photos)

The full 4th U.S. Circuit Court of Appeals on Tuesday refused to disturb a three-judge panel’s decision striking down as unconstitutional Maryland’s law aimed at preventing unwarranted price increases of generic drugs, leaving the state with little options other than to seek review by the U.S. Supreme Court.

Read More »

Supreme Court’s sales tax ruling makes case for Md. drug-price controls, Frosh says

Attorney General Brian E. Frosh Wednesday spoke in favor of legislation that would give the money raised by the increased eviction filing fee to the financially strapped Maryland Legal Services Corp., which funds groups that provide free legal services to low-income Marylanders. (The Daily Record/File Photo)

The U.S. Supreme Court’s decision last week permitting states to impose sales taxes on online purchases should save a legally embattled Maryland law aimed at preventing excessive price increases by the generic-drug industry, according to the state attorney general’s office.

Read More »

Generic-drug industry tells 4th Circuit to let price-gouging ruling stand

A law scheduled to go into effect next month would prohibit a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug and gives the Maryland attorney general the power to order the manufacturer to submit a statement explaining the reasons behind a significant price increase. (Deposit Photos)

Generic-drug makers and distributors have urged the full 4th U.S. Circuit Court of Appeals to let stand a three-judge panel’s decision last month striking down as unconstitutional Maryland’s law aimed at preventing unwarranted price increases by their industry.

Read More »

4th Circuit strikes down Md.’s generic drug price-gouging law

A law scheduled to go into effect next month would prohibit a manufacturer or wholesale distributor from engaging in price gouging in the sale of an essential off-patent or generic drug and gives the Maryland attorney general the power to order the manufacturer to submit a statement explaining the reasons behind a significant price increase. (Deposit Photos)

A divided federal appeals court Friday struck down a Maryland law designed to prevent unwarranted price increases by the generic-drug industry, saying the statute unconstitutionally encroaches on Congress’ province to regulate interstate commerce.

Read More »